Zana Technologies
Zana — Voice AI for healthcare
Zana applies artificial intelligence to the human voice to generate validated digital biomarkers and patient-facing voice journaling tools. The company develops a secure SaaS platform that collects voice recordings (mobile app or call centre) and delivers clinically validated health insights and predictions to healthcare systems and clinical research teams.
What we do
We focus on non-invasive monitoring and early detection in cardiology and respiratory care, including voice biomarkers for heart failure, COPD and asthma. Zana combines deep research, regulatory expertise and real-world clinical partnerships to translate voice signals into actionable health scores used for remote monitoring, clinical trials and care pathway integration.
- Validated voice biomarkers and clinical studies
- AI-powered SaaS platform and APIs for integration
- Voice-based patient companions and trial companion apps
Mission, history & partners
Founded in 2018 and based in Germany (HQ: Karlsruhe, office: Berlin), Zana is driven by ethical use of AI and collaboration with hospitals and research centres. Notable partners and collaborators include Maastricht UMC+, University Hospital of Würzburg, Fraunhofer IPA and industry partners. Zana holds a medical device CE mark for its AI-driven monitoring platform and leads clinical studies to validate voice biomarkers.
Contact: [email protected]